Skip to main content

Table 3 SIBO rate in Chinese IBS-D patients pre- and post- rifaximin treatment

From: Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome

  LHBT 95% CI (%) P value
  Positive/N (%) Negative/N (%)
Pre-treatment 45 (57.7) 33 (42.3) 46.5–68.9 <0.001
Post-treatment 25 (32.1) 53 (67.9) 21.5–42.6
  1. Note: SIBO, Small intestinal bacterial overgrowth; IBS, Irritable bowel syndrome; IBS-D, diarrhea-predominant IBS